Dr. Cross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-362-1408Fax+1 314-747-1345
Summary
- Dr. Anne Cross, based in Saint Louis, MO, is a neurologist with a subspecialty in neuroimmunology and multiple sclerosis. She earned her medical degree from the University of Alabama School of Medicine in 1980 and completed extensive training in neurology and pathology at several prestigious institutions, including the National Institutes of Health and Albert Einstein College of Medicine. Dr. Cross specializes in multiple sclerosis, with research focusing on pain measurement and neuromuscular medicine. Her recent publications have appeared in high-impact journals such as Annals of Neurology and The Lancet. Neurology. She has participated in clinical trials and received several accolades, including CMS Meaningful Use Stage 1 Certification and the President's Achievement Award from Barnes-Jewish Hospital Foundation.
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pathology-Anatomic and Clinical, 1987 - 1990
- Albert Einstein College of MedicineFellowship, Neuropathology, 1987 - 1990
- Clinical Center at the National Institutes of HealthResidency, Neurology, 1984 - 1986
- National Institutes of Health Clinical CenterFellowship, Neuroimmunology & Multiple Sclerosis, 1984 - 1986
- George Washington UniversityResidency, Neurology, 1981 - 1984
- Scripps Mercy HospitalInternship, Transitional Year, 1980 - 1981
- University of Alabama School of MedicineClass of 1980
- University of South AlabamaBS, Chemistry, Summa Cum Laude, 1976
- University of South AlabamaBS, Chemistry, Summa Cum Laude, 1976
Certifications & Licensure
- IL State Medical License 2020 - 2026
- MO State Medical License 1991 - 2026
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- President's Achievement Award Barnes-Jewish Hospital Foundation, 2010
- "Hall of Fame" for Researchers National MS Society, 2006
- Join now to see all
Clinical Trials
- A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) Start of enrollment: 2007 Mar 01
Publications & Presentations
PubMed
- Increased White Matter Aerobic Glycolysis in Multiple Sclerosis.Matthew R Brier, Bradley Judge, Chunwei Ying, Amber Salter, Hongyu An
Annals of Neurology. 2025-04-01 - Claustrum Volume Is Reduced in Multiple Sclerosis and Predicts Disability.Nicole Shelley, Bradley Judge, Dmitriy A Yablonskiy, Robert T Naismith, Matthew R Brier
Annals of Clinical and Translational Neurology. 2025-03-13 - Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity.Miguel Tolentino, Francesca Pace, Dana C Perantie, Robert Mikesell, Julia Huecker
Multiple Sclerosis and Related Disorders. 2025-02-01
Journal Articles
- Interleukin-10 Overexpression Promotes FasL-ligand-dependent Chronic Macrophage-mediated Demyelinating PolyneuropathyDace DS, Stark JL, Kelly J, Cross AH, Apte R, PLoS ONE
- Single Scan Quantitative Gradient Recalled Echo MRI for Evaluation of Tissue Damage in Lesions and Normal Appearing Grey and White Matter in Multiple SclerosisXiang B, Wen J, Cross AH, Yablonskiy DA., J Magn Reson Imaging, 1/29/2018
- A case report of oligodendroglioma and multiple sclerosis: Occam�s razor or Hickam�s dictum?Shirani A, Wu GF, Giannini C, Cross AH., BMJ Case Rep, 1/28/2018
- Join now to see all
Books/Book Chapters
Lectures
- Dr. Murray B. Bornstein Lectureship: The role of B cells in multiple sclerosisDartmouth-Hitchcock Medical Center and Geisel School of Medicine at Dartmouth, Lebanon NH - 1/2/2018
- B cell targeting agents: mechanisms of action in RRMS and PPMSSan Diego, CA - 1/2/2018
- Disease modifying treatment in progressive multiple sclerosis.1/1/2018
- Join now to see all
Other
- Estriol Combined with Glatiramer Acetate for Women with Relapsing-remitting Multiple Sclerosis: A Randomized, Placebo-controlled Pahse 2 TrialVoskuhl RR, Wang H, Wu TCJ, Sicotte NL, Nakamura K, Kurth F, Itoh N, Bardens J, Bernard JT, Corboy JR, Cross AH, Chib-Jalbut S, Ford CC, Frohman EM, Giesser B, Jacobs ..., Lancet Neurology
1/24/2015
Press Mentions
- Multiple Sclerosis Patients Less Likely to Develop Alzheimer’s Disease, Study FindsAugust 28th, 2024
- Could Having MS Help Shield Against Alzheimer's Disease?August 27th, 2024
- MS May Protect Against Alzheimer's DiseaseAugust 26th, 2024
- Join now to see all
Committees
- member of scientific advisory board, International Progressive MS Alliance 2022 - Present
Professional Memberships
- Fellow
- American Neurological AssociationMember
- Member
- America's Committee for Treatment and Research on MSAdvisory Committee member
- Consortium of MS CentersExecutive Committee / member of the Board of Directors/ past President
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: